AMWD vs GILD · P/E 8.7, rev $1.71B vs P/E 18, rev $7.80B
American Woodmark Corporation (AMWD) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
American Woodmark Corporation (AMWD) is a furnishings, fixtures & appliances company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported AMWD revenue for 2025-04-30 was $1.71B. Net income was $99.5M. Revenue was down 7.5% from 2024-04-30 to 2025-04-30. AMWD currently screens at market cap $836.0M and trailing P/E 8.7.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
AMWD currently screens at market cap $836.0M and trailing P/E 8.7. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the AMWD and GILD stock pages for the full models.
Not investment advice.